Levofloxacin
(Levaquin) |
Category:
Description:
Indications:
-
Acute
maxillary sinusitis (S.
pneumoniae, H. influenzae, M. catarrhalis)
-
Acute
bacterial exacerbation of chronic bronchitis (H.
influenzae, H. parainfluenzae, M. catarrhalis, S. aureus, S.
pneumoniae)
-
Community-acquired
pnemonia (S. aureus, S.
pneumoniae, H. influenzae, H. parainfluenzae, K. pneumoniae,M.
catarrhalis, Chlamydia pneumoniae, Legionella pneumophila,Mycoplasma
pneumoniae)
-
Skin
infections (S. pyogenes, S.
aureus)
-
Complicate
urinary tract infections (Enterbacter
cloacae, Enterococcus faecalis, E. coli, K. pneumoniae, P. mirabilis,
P. aeruginosa)
-
Uncomplicated
urinary tract infections (E.
coli, K. pneumoniae, S. saprophyticus)
-
Acute
pyelonephritis (E. coli)
Contraindications:
Precautions:
-
Pregnancy
category C
-
May
cause photosensitivity reactions
-
May
cause pseudomembranous colitis
-
Do
not use in young children due to possible cartilage abnormalities
-
May
cause ophthalmologic abnormalities
-
Administer
on an empty stomach
-
Do
not take with antacids, iron, aluminum, magnesium or zinc
preparations, milk or dairy products, take 2 hours before or 2 hours
after
-
May
cause dizziness or lightheadedness, use caution when performing tasks
-
Take
each dose with a full glass of water
-
Complete
full course of therapy
-
Administer
by IV infusion only over a period of not less than 60 minutes, DO NOT
administer by IM, intrathecal, intraperitoneal or SQ
-
Dosage
modifications are required in patients with renal impairment
Adverse
Reactions (Side Effects):
|
Dosage:
-
Administered
orally (tablets) and by IV injection
-
Acute
bacterial exacerbation of chronic bronchitis:
-
Community-acquired
pneumonia:
-
Acute
maxillary sinusitis:
-
Uncomplicated
skin infection:
-
Complicated
UTIs:
-
Uncomplicated
UTIs:
-
Acute
pyelonephritis:
|
|
|
|
The information contained here is an
abbreviated summary. For more detailed and complete information, consult the
manufacturer's product information sheets or standard textbooks
Source: Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
This information is provided by The Brookside Associates. The Brookside
Associates, LLC. is a private organization, not affiliated with any governmental
agency. The opinions presented here are those of the author and do not
necessarily represent the opinions of the Brookside Associates or the Department
of Defense. The presence of any advertising on these pages does not constitute
an endorsement of that product or service by either the US Department of Defense
or the Brookside Associates. All material presented here is unclassified.
C. 2009, 2014, All Rights Reserved
|
|